Expert Interview
Examining the benefits of Abbott's TriClip device compared to medical therapy for tricuspid regurgitation
Ticker(s): ABT, EWInstitution: University of Utah Medical Center
- Assistant Professor of Medicine and Medical Director of the Cardiovascular ICU at the University of Utah.
- Manages several patients with tricuspid regurgitation and has referred for the Abbott TriClip device.
- Research interests include advanced heart failure and reducing heart disease within the South Asian community; Has published research in leading cardiovascular journals including the Journal of American College of Cardiology and Circulation.
Please describe your background and patient setting.
Added By: ben_adminHow many patients with tricuspid regurgitation do you manage?
Added By: ben_adminWhat is the current standard of care for tricuspid regurgitation?
Added By: ben_adminHow many patients have you referred for Abbott's TriClip device?
Added By: ben_adminWhat is your opinion on the data from the Triluminate study?
Added By: ben_adminDo you think the use of Abbotts TriClip will increase or decrease because of this data?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
